Class IB P-type ATPases (P IB -type ATPases) that perform active transport of heavy metals across cellular membranes are of crucial importance for heavy-metal homeostasis [1] [2] [3] . The Cu + -ATPase subclass (CopA), the most widespread among P IB -type ATPases, has attracted particular attention because malfunction of the human members ATP7A and ATP7B is the direct cause of the severe Menkes' and Wilson's diseases, respectively 4, 5 . To understand the under lying mechanisms of heavy-metal transport and disease, the transport pathway and its coupling to the ATPase reaction cycle must be described. The mechanistic view of how P-type ATPases mediate ion flux across the membrane has emerged primarily from studies of P IItype ATPases, such as the sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA) [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] (Fig. 1a) . The E1 state binds intracellular ions with high affinity, and then occlusion and phosphorylation (forming the E1P state) trigger conformational changes and access to the extracellular (luminal) environment (forming the E2P state). The ions are then released, and extracellular (luminal) counterions (protons for SERCA) bind and stimulate reocclusion and dephosphorylation (during which the E2.P i transition state is formed; P i , inorganic phosphate). Release of bound phosphate yields the fully dephosphorylated conformation (E2), which then shifts into the inward-facing conformation (E1) to initiate a new reaction cycle. As a result, SERCA transports two calcium ions and countertransports two to three protons, and this is accompanied by ATP turnover and structural rearrangements 16 . However, it is not clear whether a similar E1↔E2 reaction scheme applies to other classes of P-type ATPases, particularly those for which countertransport may not apply, such as the P IB -type ATPases 17 .
a r t i c l e s between the two LpCopA TM domains indicates that CopA couples the dephosphorylation event and occlusion of the TM domain differently than do the P II -type ATPases, for which this state is associated with closure of the extracellular pathway. The MD simulations and crystal structure showed overlapping water molecules that indicate that the TM domains of the E2.P i and E2P states are both open toward the extracellular side, thus suggesting a class-specific ion-release pathway originating from ion-binding residues deep within the TM domain. These results may also explain why multiple Menkes' and Wilson's disease mutations are found in the equivalent regions of the human ATP7A and ATP7B transporters.
RESULTS

MD simulations suggest the E2.P i state to be open
By means of an MD simulation of the LpCopA E2.P i structure embedded in a dioleoylphosphocholine (DOPC) lipid bilayer, we searched the TM domain for pathways that link suggested areas of Cu + entry, intramembranous binding and exit. We surprisingly observed extracellular bulk water entering the TM domain and solvating the putative exit-site region at Glu189, occasionally reaching as far as the intra membranous copper-binding residues Cys382, Cys384 and Met717 (Fig. 1c,d and Supplementary Movie 1) . The open E2.P i state hints at a class-specific release mechanism distinct from the one observed for SERCA, in which the corresponding state is closed (Fig. 1a) . As for Ca 2+ release in SERCA, Cu + must pass more than half of the membrane from the intramembranous ion-binding residues Cys382 and Met717 to be released to the extracellular side. However, the LpCopA extrusion pathway, involving TM helices M2 (with Glu189), M6 and the P IB -specific N-terminal MA (Fig. 1b) 2 , appears to be unique.
Crystal structure of the E2P state
The results of the MD simulation led us to crystallize LpCopA in a copper-free E2P state, using the phosphate analog BeF 3 − , which in SERCA yields the phosphoenzyme state that exposes the extra cellular (luminal) release pathway 13 . The structure, determined at 2.8-Å resolution ( Fig. 2 and Table 1) , revealed a similar configuration of the intracellular domains as for the corresponding E2P conformation of SERCA ( Fig. 2b and Supplementary Fig. 1a) . The TGE loop of the A domain interacts with the phosphorylated Asp426 (mimicked by BeF 3 − binding, Supplementary Fig. 1b -e) but is not primed for dephosphorylation. However, in contrast to SERCA, in which the E2P-to-E2.P i transition is accompanied by structural changes of TM helices M1 and M2, and M3 and M4 relative to the M5-M10 bundle that occludes protons from the extracellular side in the structure (r.m.s. deviation backbone 1.7 Å, Fig. 3a) , the TM domain of LpCopA remained almost unchanged in the shift from E2P to E2.P i (r.m.s. deviation backbone 0.6 Å, Fig. 3b ). Furthermore, two independent E2P crystal forms yielded similar crystal structures, so the structural differences between SERCA and LpCopA are not likely to be due to crystal-packing effects ( Supplementary Fig. 2 and Table 1 ).
The pathway coincided in the structures and simulations
Interestingly, multiple crystal waters in the new E2P structure delin eated a pathway (Fig. 2a,c) , flanked by transmembrane helices MA, M2 and M6, that coincided with the hydration patterns derived from the MD simulation of the E2.P i structure. This extracellular water cleft was also reproduced in an MD simulation of the E2P structure (Figs. 3c and 4a and Supplementary Movies 1 and 2), in which bulk water established a link between the putative exit site at Glu189 and the extracellular environment. Our combined simulation and crystallographic data therefore indicate the E2.P i and E2P conformations of LpCopA to be equally open toward the extracellular side with water reaching the internal ion-binding sites deep in the TM domain. At the same time, the protein remained closed toward the intracellular side, as required for an alternating access mechanism 20 .
We then asked whether the observed water-filled pathway could accommodate Cu + ions, which is a prerequisite for ion transport. We calculated an outline of the pore radii in LpCopA from the Cys382, Cys384 and Met717 high-affinity ion-binding cluster to the extra cellular side, using CAVER 21 . Indeed, both crystal structures as well as average structures from the simulations reported pathway dimensions compatible with passage of Cu + ions 22 ( Fig. 3d and Supplementary  Fig. 3h,i) . To enable a comparison to the LpCopA crystal structures, we stripped hydrogens from average structures from the simulations. Even so, the release-pathway radius in the simulated hydrogenated average structures was wider than was the Cu + ion radius. Similarly, analyses of the pore radii of the corresponding E2.P i (PDB 3B9R 13 ) and E2P (PDB 3B9B 13 ) SERCA states (without hydrogens), with the origin set close to the internal ion-binding sites defined by Ile307, Glu309 and Leu797, displayed an open E2P state in agreement with ion extrusion (Fig. 3d) , whereas we found no pores for the E2.P i state, results in accordance with a proton-occluded state. Functionally relevant residues are shown as sticks. Lipid phosphates and water are shown as orange and red density surfaces at 5% and 20% occupancies, respectively (the fraction of presence in simulation frames). (d) Density plot for the water distribution of the E2.P i MD simulation showing the number of water molecules within 7 Å from the protein relative to bulk solution along the membrane normal (intracellular side is positive). The centers of mass with corresponding error bars are depicted for Cys382, Met717, Glu189 and Ala714. Error bars, s.d. (n = 100,000).
a r t i c l e s
The identified conduit allows for transfer of Cu + We observed pronounced side chain dynamics of Met717 and Glu189 that could be attributed to a possible role in shuttling of Cu + ions from the internal binding residues via the exit site to the extracellular compartment (Fig. 4a) . To investigate the role of Met717 and Glu189 and the energetics involved in ion passage, we positioned a Cu + ion between the intramembranous high-affinity ligands Cys382 and Met717 and simulated its release. Even though the force applied on the ion was strictly perpendicular to the membrane, the ion followed our proposed release pathway, involving a 10-Å traverse movement in the membrane plane (Fig. 5) . Met717 shuttled Cu + to Glu189, which then released the ion to the water-filled extracellular cavity. We detected no major energy barriers along the pathway, and the passage between Met717 and Glu189 was associated with favorable energetics (Fig. 5 ).
An intramembranous Cu + site
Comparison of the crystal structure and MD simulations revealed additional details of the exit pathway, including preferred locations for water molecules. Two crystallographic water molecules were located adjacent to critical residues implicated in high-affinity copper binding 19 and contributed to water pockets that were continuously occupied in the E2P simulation. Importantly, water pockets were also present at similar locations in the E2.P i simulation. Even though water molecules associated with the release pathway in the E2.P i simulation displayed high exchange rates, as defined by short residence times (<20 ps, Fig. 4a and Supplementary Fig. 3f,g ), the water pockets remained occupied throughout the simulation. Crystal waters and simulated water dyna mics have been used previously to probe ion-binding sites 23, 24 , and, remarkably, the internal water pockets in the simulations correspond by structural alignment to calcium site I of the occluded Ca 2 -bound E1P conformation of SERCA (Fig. 4a) . Therefore, the internal water pockets hint at a role of this site in copper transport.
Residues along the ion conduit are critical for function
To further validate the proposed ion conduit and mechanisms involved in ion release, we performed in vitro activity measurements of CopA point mutants, using a well-established ATPase assay 25 ( Fig. 4c, Supplementary Fig. 4a and Supplementary Table 1 ). This assay showed Met717 to be crucial for function and identified both side chain size and charge to be important at position Glu189, which in the human copper pumps is conserved as an aspartate. The substantially reduced activity for the A714T mutation can be explained by direct steric hindrance of the observed pathway. Furthermore, although Met100 and Met711 both are positioned at the proposed exit site, only Met711 displays mutational sensitivity, results consistent with the peripheral locations of Met100 and M711 relative to the pathway, with Met100 being the most distant (Fig. 4b) . All considered, the release pathway is supported by mutational effects, as probed by the ATPase activity, and provides a possible structural basis for the impaired copper-transport function resulting from previously perplexing missense mutations associated with Menkes' and Wilson's diseases, which are located in the vicinity of the extracellular − -bound LpCopA, with key residues labeled. The opening from the high-affinity Cu + -coordinating residues Cys382, Cys384 and Met717 in the E2P conformation is displayed as a red surface, as obtained with CAVER 21 , and overlays with crystallographic water molecules as red spheres. 4d) . Consistently with our findings, the extracellular loop connecting MA and MB has been implicated in copper discharge in the human copper pump ATP7A 27 .
Conserved prolines may control Cu + release
By tracking interhelical distances in the TM domain by means of Cα-to-Cα distances between helices MA and M6, M1 and M4, and M4 and M5 in the E2.P i MD simulation, we observed a shift of 3-5 Å of the extracellular ends of TM helices MA and M6 ( Fig. 4b and Supplementary Fig. 5a ,b). This structural rearrangement originated from the well-conserved Pro94 and Pro710, thus suggesting a possible role for these residues in the opening of the release pathway to the exit site at Glu189. Moreover, the CAVER analyses showed average structures from the MD simulations to be more opened toward the extracellular side as compared to the corresponding crystal structures, results consistent with the observed shifts of the extracellular ends of TM helices MA and M6 (Fig. 3d) .
In agreement with a proline-dependent opening mechanism, the in vitro assay reported impaired CopA activity for the P94A and P710A mutations ( Fig. 4c and Supplementary Table 1) . Moreover, two separate MD simulations of the proline mutants showed markedly distorted hydration patterns compared to those of wild type, thus providing a possible structural explanation for the observed phenotypes ( Supplementary Fig. 5f,g ). CAVER results on average structures from the mutant simulations predicted a misdirected pathway for the P94A mutant ( Supplementary Fig. 5c-e,f) . In the P710A simulation, the pathway from Glu189 was largely maintained, but the release a r t i c l e s pathway and water pockets at the intramembranous ion-binding li gands contained a larger amount of water compared to that of the wild-type simulation ( Supplementary Fig. 5c-e,g ). Together, the in vitro data and accompanying MD simulations support Pro710 and Pro94 as key players for pore opening and ion release. Thus, whereas the intracellular segment of helix MB appears critical for copper uptake 18 , an ion-extrusion function can be attributed to the extracellular part of MA (including Pro94), which is well conserved in Cu + -ATPases (Supplementary Fig. 6a ).
The exit pathway is physiologically relevant
To investigate the physiological significance of the proposed release pathway and mutations, we assessed the CopA mutations in vivo by LpCopA complementation of a CopA-deficient Escherichia coli strain, using LpCopA constructs controlled by the CopA promoter of the host ( Fig. 4c and Supplementary Fig. 4b,c) . A possible caveat with this approach is that extracellular Cu + -accepting partners may be missing or incapable of recognizing the recombinant ATPase. However, because the D426N dead mutant (with no phosphoryl ation site) and wild-type LpCopA switched the copper tolerance of the E. coli strain, it was possible to use the assay as a proxy for functional Cu + transport in vivo. Overall, the general trends from ATPase activities in vitro were reproduced in vivo, albeit less pronouncedly (Fig. 4c) . Strikingly, the two most potent in vitro mutations of the region, A714T (sterical block of the conduit) and P710A (opening to the extracellular compartment), also conferred a remarkable susceptibility to copper in vivo, thus substantiating the relevance of the release pathway for CopA copper transport in cells.
DISCUSSION
The combined results from our experiments and simulations map a putative release pathway in Cu + -transporting P IB -type ATPases, which appears to be available both in the E2P and E2.P i states. The structural boundaries and chemical characteristics of this pathway, as well as the actual release mechanism, seem to be unique for the subclass. By ana logy to SERCA 16 , the CopA transport mechanism might also involve counterions such as protons. However, so far, counterion requirements have not been observed for any P IB -type ATPase, and currents observed for the human copper transporter ATP7B are not sensitive to pH 28, 29 . The unexpected open configuration of the E2.P i structure also disfavors coupled countertransport of, for example, protons, for which occlusion of the TM domain would be expected (Fig. 6) .
Further supporting a distinctly tuned reaction cycle for Cu + -ATPases, the ATP-induced phosphoenzyme formation has been observed in the absence and in the presence of the transported ion, unlike results for SERCA 30 . The unique features accompanying P IB -type ATPase function can be explained in terms of substantial structural differences between P II -and P IB -type ATPases. For instance, the A domain-M1 linker that controls the Ca 2+ -entry region in P II -type ATPases is lacking in CopA. Because the A domain has a key role in transmitting conformational changes in the intracellular domains to changes in the TM domain, the missing linker might therefore offer a structural explanation to the differently tuned coupling between dephosphory lation and TM occlusion. The presence of the two additional TM helices MA and MB in CopA may also explain why their main interac tion partners, M1 and M2, are prevented from undergoing the major structural rearrangements observed in SERCA. Furthermore, CopA lacks the M7-M10 bundle, which in P II -type ATPases (SERCA and Na + ,K + -ATPase) contains a solvated channel in the E2 and E2.P i states that presumably supports proton exchange 31 (Fig. 1b) . This mechanistic differentiation may also apply within the P IB -type ATPase subclasses; the MA helix in Zn 2+ -and Co 2+ -ATPases is lacking the corresponding Pro94, and the extracellular portion is less conserved compared to that of Cu + -ATPases (Supplementary Fig. 6 ). Notably, distinct mechanisms within subfamilies are also observed in, for example, ABC transporters 32 . Our E2P crystal structure and MD simulations of LpCopA in combination with mutational analyses support a unique release mechanism for Cu + P IB -type ATPases. The observed extracellular release pathway is likely to be involved in specific and controlled delivery to Cu + -acceptor chaperones 33 , thus preventing detrimental effects of free copper in the extracellular space, or to other cuproproteins that need the ion for function 34, 35 . The pathway further explains why Menkes' and Wilson's mutations in this region impair the function of ATP7A and ATP7B. The high prevalence and critical function of P IB genes in pathogenic bacteria for intraphagolysosomal copper defense 36, 37 and the mutation sensitivity of the exit pathway point to a putative site for inhibitors with favorable access from the outside of the cells, Figure 1b , with the known structures of the reaction cycle highlighted with bright colors. Colored arrows indicate the coming movements of the corresponding domains. In contrast to those of the well-characterized calcium P-type ATPase SERCA 16 , no major movements are identified between the transmembrane domains of the E2P and E2.P i LpCopA states, thus indicating a class-specific transport mechanism with an open release pathway associated with dephosphorylation. npg similar to cardiotonic steroids and omeprazole, which are clinically used inhibitors of Na + ,K + -ATPase and H + ,K + -ATPase. 
METHODS
Methods
ONLINE METHODS
Sample preparation. LpCopA mutants were generated with Agilent Technologies' QuikChange Lightning site-directed-mutagenesis kit with the full-length nontagged lpg1024 gene in pET22b(+) (Novagen). Cell growth to solubilization, in the detergent C 12 E 8 (octaethylene glycol monododecyl ether), and ultracentrifugation were conducted as described previously 18 . For crystallization, the sample was further purified according to this protocol, whereas each construct for in vitro characterization was loaded onto a separate pre-equilibrated 5-ml affinity column, either GE Healthcare HisTrap HP or Qiagen Ni-NTA Superflow Cartridge, washed with 20 mM Tris-HCl, pH 7.6, 200 mM KCl, 1 mM MgCl 2 , 20% glycerol, 5 mM β-mercaptoethanol (BME) and 0.28 mM C 12 E 8 , and eluted with 500 mM imidazole. The buffer of the concentrated protein was thereafter exchanged with a GE Healthcare HiTrap Desalting column to 20 mM MOPS-KOH, pH 6.8, 80 mM KCl, 1 mM MgCl 2 , 20% glycerol, 5 mM BME and 0.28 mM C 12 E 8 . The constructs were concentrated and the purity estimated with SDS-PAGE. To assess relative protein concentrations, the intensity of individual LpCopA bands at ~75 kDa were quantified with ImageJ 39 . A second SDS-PAGE gel (Supplementary Fig. 4a ) was generated with equal protein amounts, as calculated from the first gel. The protein concentration of the D426N mutant was determined with light absorbance at 280 nm and used as reference in the activity assay (described below).
In vitro characterization. The Baginski method with arsenic detection under aerated conditions was used to assess ATPase activity 25 . Measurements were conducted with equal amounts of protein for each construct as judged by ImageJ (and shown in Supplementary Fig. 4a ), corresponding to 3.8 µM for D426N, 40 mM MOPS-KOH, pH 6.8, 150 mM NaCl, 5 mM KCl, 5 mM MgCl 2 , 20 mM (NH4) 2 SO 4 , 20 mM l-cysteine, 5 mM NaN 3 , 0.25 mM Na 2 MoO 4 , 1.2 mg/ml l-α-phosphatidylcholine lipids from soybean and 3.7 mM C 12 E 8 in a total volume of 50 µl. 10 µM ammonium tetrathiomolybdate was added to prevent activity from background copper contaminants, and the protein was incubated for 15 min with 1 mM CuCl 2 (reduced to Cu + ). Reactions were started by addition of 4. Table 1a ) were thereafter scaled (Supplementary Table 1b) to account for the subtle variations in the relative intensities of Supplementary Figure 4a . These data were then plotted on a scale of 100% (wild-type LpCopA activity) to 0% (D426N mutant activity), through removal of the background of the D426N dead mutant (Fig. 4c) . One experiment with nine replicates was done for the in vitro activity data. To assess the reproducibility of our assay, two mutations were tested with an additional independent experiment (Supplementary Fig. 4d) .
In vivo characterization. The E. coli CopA-deleted strain CN2328, its progenitor strain CN1709 and the plasmid pCN2345 containing the native E. coli CopA promoter used here have been described previously 40 . pCN2345 was mutated to allow replacement of E. coli CopA with LpCopA with maintained promoter and wild-type and mutant LpCopA incorporated separately. The plasmids were then transformed into CN2328, and an empty pET22b(+) vector was transformed into CN1709 cells and used as a control. Precultures were grown overnight and their OD 600nm adjusted to 1.0 before inoculation. 10 µl of cells were used to inoculate 190 µl of LB medium with 100 µg/ml ampicillin, and CuCl 2 concentrations were adjusted to 0 and 3 mM. The inoculated media were grown in 96-well plates in a shaking incubator at 37 °C, and OD 560nm was measured in hourly intervals with a PerkinElmer VICTOR3 multilabel plate counter. (The growth curves of the cells at different CuCl 2 concentrations are shown in Supplementary Fig. 4b,c , and the final time point for 3 mM CuCl 2 is shown in Fig. 4c.) Three independent experiments were conducted, with 3 replicates each for the first and third experiments, and 15 replicates for the second experiment. The averaged value of the averages for each mutant in every independent experiment at the final time point for 3 mM CuCl 2 was used in Figure 4c , and wild-type LpCopA activity was set as 100%. Error bars were calculated by three data points per mutant per experiment. The three data points of the second experiment were selected by taking the lowest, highest and most average value for each mutant from the 15 replicates. M100L was not cloned for the in vivo assay.
Crystallization, data collection and model building. Crystallization of the LpCopA E2-BeF 3 − complex was performed by hanging-drop vapor diffusion. 0.15 ml 10 mg/ml LpCopA was relipidated for 16 h according to the HiLiDe method 41 with 0.5 mg DOPC and between 5 µl and 12 µl 100 mg/ml C 12 E 8 . The sample was centrifuged for 10 min at 100,000g and incubated with 10 mM NaF, 3.2 mM EGTA, 10 µM ammonium tetrathiomolybdate (TTM) and 2 mM BeSO 4 . The best crystals (in the space group C2) were found after two days with 5 mM β-NAD in the protein solution and a precipitant solution containing 10% glycerol, 200 mM KCl, 3% t-BuOH, 14% PEG 2K MME and 5 mM BME mixed 1:1 with the protein solution. The P2 1 2 1 2 1 crystal form, displaying a different packing, grew by addition of 36.7 mM Fos-choline-10 to the protein solution. Screening of diffraction properties was conducted at Maxlab, SLS and ESRF, and final data were collected at ID29 at ESRF with a wavelength of 0.9763 Å, a temperature of 100 K and a pixel detector (Pilatus 6M) and scaled with XDS 42 . Initial phases were obtained by molecular replacement with Phaser 43 with the E2-AlF 4 − structure of LpCopA (PDB 3RFU 18 ) as a search model. Iterative refinement and model building were performed with Phenix 44 and the molecular graphics program Coot 45 . The low-resolution E2-BeF 3 − structure (P2 1 2 1 2 1 crystal form) was determined with Phaser with the above high-resolution structure as a search model (PDB 4BBJ) and subjected to rigid-body refinement in Phenix 44 . Structures were analyzed with MolProbity, which indicated that 96.2, 3.0 and 0.8% of the residues were in the favored, allowed and nonfavored regions, respectively, for the highresolution structure (in space group C2).
Building the MD systems. For the E2.P i state (based on the E2-AlF 4 − structure, PDB 3RFU 18 , chain A) and E2P state (E2-BeF 3 − , PDB 4BBJ), proteins with ligands were inserted into the lipid bilayer by alignment of the centers of mass of the TM region and a 500-molecule DOPC bilayer (built with the CHARMM-GUI membrane builder 46 ) and solvated in excess water. Alternative docking methods resulted in similar insertion depths (data not shown) 47, 48 . Electric neutrality was achieved by addition of seven and nine Na + counterions to the E2.P i and E2P system, respectively. The E2.P i P94A and P710A mutants, generated with the VMD plugin psfgen 49 , were constructed in a similar fashion.
MD simulation. After a 10,000-step conjugate-gradient energy minimization and gradual heating from 0 to 310 K over 120 ps, two consecutive 1-ns simulations at constant temperature (310 K) and volume (NVT ensemble) equilibrated lipids and water molecules, respectively. The protein was then progressively released from its initial configuration over seven 1-ns simulations, and this was followed by a production run at constant temperature (310 K) and pressure (1 atm) (NPT ensemble). The production runs for the wild-type, P94A and P710A E2.P i states were 100 ns, and for the E2P state was 85 ns. Molecular dynamics simulations were run with the NAMD 2.7 package 50 . The CHARMM22 including CMAP correction and CHARMM36 force fields 51, 52 were used for protein and lipids, respectively, and the TIP3P model was used for the water molecules 53 . A time step of 1 fs was used to integrate the equations of motion, and a reversible multiple-time-step algorithm 54 of 4 fs was used for the electrostatic forces and 2 fs for short-range, nonbonded forces. The smooth particle mesh Ewald method 55, 56 was used to calculate electrostatic interactions. The short-range interactions were cut off at 12 Å. All bond lengths involving hydrogen atoms were held fixed with the SHAKE 57 and SETTLE 58 algorithms. A Langevin dynamics scheme was used for thermostating, and Nosé-Hoover-Langevin pistons were used for pressure control 59, 60 . Molecular graphics and simulation analyses were generated with the VMD 1.8.7 package 49 . The evolution of the simulation cell dimensions shows the simulations to equilibrate within 20 ns (Supplementary Fig. 3a,b) . The r.m.s. deviation for the E2.P i -state simulations were relatively high (>4 Å), whereas the E2P state was less flexible, with an r.m.s. deviation of ~2 Å ( Supplementary  Fig. 3c,d) . The relatively high values of r.m.s. deviations for the E2.P i -state simulations stemmed from the large soluble headpiece because the TM domain displayed substantial stability, reaching a plateau at ~2 Å after 20 ns. To account for the underlying structural factors for the large r.m.s. deviation, we measured the evolution of the centers of mass (COM) for the A/N/P domains ( Supplementary  Fig. 3e ). We note substantial COM stability in all dimensions for the individual domains and conclude that the large r.m.s. deviation stems from inherent flexibility of the domains and loop regions rather than from rigid-body motions.
MD simulation with Cu + . To describe the energy barriers involved in transport of Cu + along the water-filled pathway, the potential of mean force (PMF) was calculated with GROMACS 4.6.3 (ref. 61 ) and the ffGromos53a6 force field 62 , which contains Cu + parameters. The last frame of the CHARMM E2.P i simulation was formatted according to the Gromos force field, and a Cu + ion was placed between ion-coordinating residues Cys382 and Met717. The DOPC lipids and water molecules were described by parameters derived from the ffGromos53a6 force field 63 and the simple point charge (SPC) water model 64 , respectively. The system was first energy-minimized according to a steepest descent algorithm for 5,000 steps. The GROMACS pull code was used to generate configurations for the umbrella sampling with a 1,000 kJ mol −1 nm −2 force constant applied on Cu + in the z dimension directed toward the extracellular side. A pull rate of 2.5 Å/ns was applied for 10 ns. The Cα atoms of six remote residues (111, 115, 169, 367, 706 and 709) were restrained to keep the system from drifting when applying the force. A 2-fs time step was used, and short-range nonbonded interactions were cut off at 1.4 nm, with long-range electrostatics calculated with the particle mesh Ewald (PME) algorithm 55, 56 . The temperature of the system was maintained by independent coupling of the protein and nonprotein atoms to an external temperature bath at 310 K with a Nose-Hoover thermostat 65, 66 , and the Parrinello-Rahman barostat 67, 68 was used to isotropically regulate pressure. The length of all bonds within the protein was constrained with the LINCS algorithm 69 . Snapshots spaced by 1 Å were taken from the pulling simulation to generate the starting configurations for the umbrella-sampling windows. Each window was equilibrated for 100 ps and was followed by 5 ns of umbrella sampling and then extraction of the PMF with the weighted histogram analysis method 70 , implemented in the GROMACS package 38 . Statistical errors were quantified by bootstrap analysis. Figures. Figures 1c,d, 4a ,b and 5 in the main text were made with VMD 49 , and Figures 2, 3a ,b and 4d were done with PyMOL (http://www.pymol.org/).
